EKSO
Ekso Bionics Holdings Inc
NASDAQ: EKSO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$12.01
+4.98% today
Updated 2026-04-30
Market cap
$39.16M
P/E ratio
—
P/S ratio
3.06x
EPS (TTM)
$-4.91
Dividend yield
—
52W range
$3 – $14
Volume
0.1M
Ekso Bionics Holdings Inc (EKSO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.71M | $3.30M | $5.33M | $8.66M | $14.22M | $7.35M | $11.33M | $13.92M | $8.88M | $11.25M | $12.91M | $18.28M | $17.93M | $12.80M |
| Revenue growth (YoY) | — | +22.0% | +61.3% | +62.6% | +64.2% | -48.3% | +54.1% | +22.8% | -36.2% | +26.6% | +14.8% | +41.6% | -1.9% | -28.6% |
| Cost of revenue | $2.34M | $2.71M | $3.77M | $7.48M | $11.27M | $5.28M | $7.02M | $7.15M | $3.81M | $4.50M | $6.70M | $9.20M | $8.41M | $5.95M |
| Gross profit | $370000.00 | $587000.00 | $1.56M | $1.18M | $2.95M | $2.07M | $4.31M | $6.76M | $5.07M | $6.75M | $6.21M | $9.08M | $9.51M | $6.84M |
| Gross margin | 13.7% | 17.8% | 29.3% | 13.6% | 20.7% | 28.1% | 38.0% | 48.6% | 57.1% | 60.0% | 48.1% | 49.7% | 53.1% | 53.5% |
| R&D | $6.09M | $3.93M | $3.87M | $6.48M | $8.88M | $9.48M | $5.85M | $4.60M | $2.47M | $2.75M | $3.63M | $5.03M | $3.87M | $3.03M |
| SG&A | $4.38M | $10941.00 | $7.40M | $7.00M | $10.85M | $10.71M | $11.70M | $7.41M | $7.70M | $10.52M | $10.99M | $10.69M | $8.79M | $9.99M |
| Operating income | $-14.24M | $-12292.00 | $-16.79M | $-21.56M | $-27.59M | $-31.61M | $-27.03M | $-16.64M | $-12.86M | $-13.83M | $-15.56M | $-15.11M | $-10.46M | $-13.33M |
| Operating margin | -526.3% | -0.4% | -315.3% | -248.9% | -194.0% | -429.9% | -238.5% | -119.6% | -144.8% | -123.0% | -120.5% | -82.7% | -58.4% | -104.1% |
| EBITDA | $-14.14M | $-10.49M | $-32.59M | $-18.64M | $-21.60M | $-26.74M | $-24.89M | $-11.06M | $-15.07M | $-9.09M | $-14.04M | $-13.20M | $-9.45M | $-9.81M |
| EBITDA margin | -522.5% | -317.7% | -611.8% | -215.3% | -151.9% | -363.7% | -219.7% | -79.5% | -169.6% | -80.8% | -108.7% | -72.2% | -52.7% | -76.7% |
| EBIT | $-14.48M | $-10.49M | $-33.33M | $-19.58M | $-23.45M | $-28.47M | $-26.39M | $-11.75M | $-15.69M | $-9.65M | $-14.92M | $-14.90M | $-11.06M | $-11.39M |
| Interest expense | $0.00 | $0.00 | $435000.00 | $13000.00 | $16000.00 | $648000.00 | $600000.00 | $384000.00 | $139000.00 | $113000.00 | $156000.00 | $302000.00 | $269000.00 | $309000.00 |
| Income tax | — | $-541.00 | $-371000.00 | $-965000.00 | $-6.17M | $944000.00 | $1.27M | $-438000.00 | $1.13M | $-1.33M | $-476000.00 | $1.53M | — | — |
| Effective tax rate | 0.0% | 4.2% | 1.1% | 4.7% | 20.8% | -3.4% | -4.9% | 3.5% | -7.7% | 12.0% | 3.1% | -11.2% | 0.0% | 0.0% |
| Net income | $-15.04M | $-12292.00 | $-33.77M | $-19.59M | $-23.47M | $-29.12M | $-26.99M | $-12.13M | $-15.82M | $-9.76M | $-15.08M | $-15.20M | $-11.33M | $-11.70M |
| Net income growth (YoY) | — | +99.9% | -274623.4% | +42.0% | -19.8% | -24.1% | +7.3% | +55.1% | -30.4% | +38.3% | -54.4% | -0.8% | +25.5% | -3.2% |
| Profit margin | -555.9% | -0.4% | -633.9% | -226.2% | -165.0% | -396.1% | -238.2% | -87.2% | -178.2% | -86.8% | -116.8% | -83.1% | -63.2% | -91.4% |